13F Holdings
中文EN

CDIX Cardiff Lexington Corp

Services-Offices & Clinics of Doctors of Medicine · OTC · SEC CIK 811222 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY0.3%
TTM net income YoY-105.9%
TTM EPS YoY16.5%
Revenue 3-yr CAGR-1.8%
Net income 3-yr CAGR—

Margins

Gross margin60.4%
Operating margin-10.9%
Net margin-92.1%
FCF margin—
EBITDA margin-10.8%

Returns

ROE-749.4%
ROA-32.9%
ROIC (approx.)-4.7%
Asset turnover0.36x

Leverage & solvency

Liabilities / assets88.3%
Debt / equity12.95x
Current ratio0.91x
Interest coverage-0.14x

Cash quality & payout

Operating cash flow / net income0.17x
Accruals ratio-27.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$11.54M$8.27M$11.85M$10.69M$9.88M
Cost of revenue$4.33M$3.84M$3.56M$4.06M$3.77M
Gross profit$7.21M$4.43M$8.29M$6.63M$6.11M
SG&A expense$5.33M$4.06M$3.08M$2.70M$4.43M
Operating income$1.10M-$193,504$5.20M$3.91M$1.66M
Interest expense$6.82M$3.05M$439,618$452,864—
Pretax income-$5.75M-$3.19M$3.11M-$3.25M-$303,612
Income tax$0————
Net income-$5.51M-$3.30M$3.03M-$5.43M$666,293
EBITDA$1.11M-$180,043$5.22M$3.93M$1.68M
EPS (basic)————-0.01
EPS (diluted)————-0.01
Weighted avg. shares (diluted)8.50M3.82M15,0015,822128.02M
Balance sheet
Cash & equivalents$318,535$1.19M$866,943$219,085$580,968
Receivables$22.07M$15.93M$13.31M$6.60M$6.01M
Current assets$22.59M$17.21M$14.18M$6.83M$6.59M
PP&E, net$2,953$21,198$34,661$55,439$78,570
Goodwill$5.67M$5.67M$5.67M$5.67M$7.76M
Intangibles————$0
Total assets$29.09M$23.93M$20.75M$13.34M$15.30M
Current liabilities$25.83M$15.89M$13.86M$9.96M$11.17M
Short-term debt—$3.62M$87,460$2.49M—
Long-term debt$18.56M$9.21M$2.28M$155,598$600,932
Total debt$18.56M$12.83M$2.37M$2.65M$600,932
Total liabilities$26.01M$16.32M$14.12M$10.19M$11.44M
Shareholders' equity-$2.47M$2.69M$731,418-$1.74M$486,840
Net debt$18.24M$11.64M$1.50M$2.43M$19,964
Shares outstanding13.70M5.10M25,12110,997166.13M
Cash flow statement
Operating cash flow-$2.85M-$2.77M-$1.81M-$1.15M-$850,141
Capital expenditure———$0$3,407
Free cash flow———-$1.15M-$853,548
Investing cash flow———$0-$2.32M
Financing cash flow$1.98M$2.98M$2.37M$788,794$3.68M
Depreciation & amortization$5,652$13,461$20,777$23,132$13,886
Stock-based compensation$754,475$544,725$0——
Dividends paid$50,000$100,000———

Free plan shows the latest 5 periods; Pro shows all 24 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.